Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 2.17 USD -7.66%
Market Cap: 5m USD

Operating Margin
Redhill Biopharma Ltd

-181.7%
Current
-33%
Average
6.6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-181.7%
=
Operating Profit
-14.6m
/
Revenue
8m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
IL
Redhill Biopharma Ltd
NASDAQ:RDHL
4.6m USD
-182%
US
Eli Lilly and Co
NYSE:LLY
756.3B USD
40%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
405.3B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK
45%
CH
Roche Holding AG
SIX:ROG
207.7B CHF
33%
CH
Novartis AG
SIX:NOVN
179.9B CHF
33%
UK
AstraZeneca PLC
LSE:AZN
165.5B GBP
24%
US
Merck & Co Inc
NYSE:MRK
211.1B USD
34%
IE
Endo International PLC
LSE:0Y5F
183.8B USD
11%
US
Pfizer Inc
NYSE:PFE
144.6B USD
27%

Redhill Biopharma Ltd
Glance View

Market Cap
5m USD
Industry
Pharmaceuticals

RedHill Biopharma Ltd. is a biopharmaceutical company focusing gastrointestinal and infectious diseases. The firm promotes three gastrointestinal drugs in the US: Movantik, Talicia and Aemcolo. Key programs in it pipeline of late-stage clinical assets include: opaganib (Yeliva) and RHB-107 for multiple indications including COVID-19, RHB-204 for pulmonary nontuberculous mycobacteria (NTM) disease and RHB-104 for Crohn's disease.

RDHL Intrinsic Value
8.59 USD
Undervaluation 75%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-181.7%
=
Operating Profit
-14.6m
/
Revenue
8m
What is the Operating Margin of Redhill Biopharma Ltd?

Based on Redhill Biopharma Ltd's most recent financial statements, the company has Operating Margin of -181.7%.

Back to Top